Portal de Periódicos da CAPES

CURRENT AND FUTURE TRENDS IN INTERVENTIONAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA IN JAPAN

1998; Lippincott Williams & Wilkins; Volume: 159; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(01)63208-7

1527-3792

Shin Egawa, Τοyoaki Uchida, Ken Koshiba,

Pelvic floor disorders treatments

No AccessJournal of UrologyClinical Urology: Original Articles1 Jun 1998CURRENT AND FUTURE TRENDS IN INTERVENTIONAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA IN JAPAN SHIN EGAWA, TOYOAKI UCHIDA, and KEN KOSHIBA SHIN EGAWASHIN EGAWA More articles by this author , TOYOAKI UCHIDATOYOAKI UCHIDA More articles by this author , and KEN KOSHIBAKEN KOSHIBA More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63208-7AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Procedures of Japanese urologists of interventional therapy for benign prostatic hyperplasia (BPH) should be defined for resource economy and policy establishment. Materials and Methods: A questionnaire was mailed to the urology departments of 80 medical schools in Japan for clarification of surgical procedures presently in use for treating bladder outlet obstruction due to BPH. Prospects for the next 5 years (year 2002) were also requested. Results: We received 76 questionnaire responses from medical school urology facilities (95%) by the end of January 1997. Standard transurethral resection of the prostate gland is and will continue to be the most common surgical procedure. Open adenectomy is the first choice for large glands but may be replaced by other interventional procedures. Laser prostatectomy and transurethral electrovaporization will be used more often for treating all severities of BPH. Conclusions: Even with increasing interest in new techniques, transurethral resection of the prostate will continue to serve as the standard therapy for BPH during the next 5 years. Transurethral electrovaporization may become established in the near future. References 1 : Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New Engl. J. Med.1995; 332: 99. Crossref, Medline, Google Scholar 2 : Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J. Urol.1989; 141: 243. Link, Google Scholar 3 : Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J. Urol.1996; 155: 181. Link, Google Scholar 4 : The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives. J. Urol.1997; 158: 105. Link, Google Scholar From the Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byNISHIZAWA K, KOBAYASHI T, WATANABE J and OGURA K (2018) Interstitial Laser Coagulation of The Prostate For Management of Acute Urinary RetentionJournal of Urology, VOL. 170, NO. 3, (879-882), Online publication date: 1-Sep-2003. Uchida T and Koshiba K (2000) Transurethral Resection of the Prostate Treatment of Benign Prostatic Hyperplasia, 10.1007/978-4-431-68444-2_15, (177-186), . Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T and Koshiba K (1999) Factors influencing morbidity in patients undergoing transurethral resection of the prostateUrology, 10.1016/S0090-4295(98)00524-X, VOL. 53, NO. 1, (98-104), Online publication date: 1-Jan-1999. Volume 159Issue 6June 1998Page: 1958-1960 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information SHIN EGAWA More articles by this author TOYOAKI UCHIDA More articles by this author KEN KOSHIBA More articles by this author Expand All Advertisement PDF downloadLoading ...